SR1555 hydrochloride is a reverse agonist of retinoic acid receptor-related orphan receptor gamma (RORγ) with an IC50 of 1 μM; it inhibits the development and function of pro-inflammatory TH17 cells and increases the frequency of anti-inflammatory regulatory T (Treg) cells; it can be used in the research of autoimmune diseases.